Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
 

 

Long Island Regional Node


The Long Island Node includes five community-based organizations with a total of over 50 treatment programs serving a culturally and ethnically diverse patient population. These programs encompass a wide variety of treatment modalities including inpatient and outpatient programs, detoxification programs, methadone maintenance, therapeutic communities, programs for adolescents, and programs for women with children. Areas of special interest and expertise within the node include: psychiatric and medical co-morbidity, HIV, adolescent treatment, women and trauma, and combined behavioral and pharmacotherapy.

 

Regional Research and Training Center

New York State Psychiatric Institute
Research Foundation for Mental Hygiene, Inc.
1051 Riverside Drive
New York, NY 10032


Principal Investigator


Edward V. Nunes, M.D.
Professor of Clinical Psychiatry,
Columbia University and New York State Psychiatric Institute
1051 Riverside Drive, Unit 51, Room 3717
New York, NY 10032
212-543-5581 (Voice)
nunesed@pi.cpmc.columbia.edu


Community Treatment Programs

Narco Freedom, Inc.
Bronx, NY

North Shore - Long Island Jewish Health Systems
Glen Oaks, NY

Phoenix House
New York, NY

St. Luke's Roosevelt Hospital Center
New York, NY

Staten Island University Hospital (affiliate of NS-LIJHS)
Staten Island, NY

 

Long Island Protocol Involvement
PROTOCOL0001 Buprenorphine/Naloxone for Opiate Detoxification - INpatient
PROTOCOL0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules
PROTOCOL0008 A Baseline for Investigating Diffusion of Innovation
PROTOCOL0009 Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy In Substance Abuse Rehabilitation Programs
PROTOCOL0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
PROTOCOL0015 Women’s Treatment for Trauma and Substance Use Disorders
PROTOCOL0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
PROTOCOL0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
PROTOCOL0021 Motivational Enhancement Treatment (MET) To Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse
PROTOCOL0028 Osmotic-Release Methylphenidate for ADHD in Adolescents with Substance Use Disorders
PROTOCOL0029 A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD
PROTOCOL0030 Prescription Opioid Addiction Treatment Study (POATS)



 

 



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, July 8, 2008. The U.S. government's official web portal